Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
Identifieur interne : 002F85 ( Main/Curation ); précédent : 002F84; suivant : 002F86Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
Auteurs : Masato Kanazawa [Japon] ; Takayoshi Shimohata [Japon] ; Masahisa Sato [Japon] ; Osamu Onodera [Japon] ; Keiko Tanaka [Japon] ; Masatoyo Nishizawa [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-03-15.
English descriptors
- KwdEn :
- Adult, Apraxias (drug therapy), Apraxias (etiology), Apraxias (physiopathology), Blepharospasm (diagnosis), Botulinum Toxins, Type A (therapeutic use), Brain Stem (pathology), Brain Stem (physiopathology), Cerebellum (pathology), Cerebellum (physiopathology), Eyelids (physiopathology), Female, Humans, Infection, Magnetic Resonance Imaging, Male, Middle Aged, Neurodegenerative Diseases (complications), Neuromuscular Agents (therapeutic use), Parkinsonian Disorders (complications), Parkinsonian Disorders (pathology).
- MESH :
- chemical , therapeutic use : Botulinum Toxins, Type A, Neuromuscular Agents.
- complications : Neurodegenerative Diseases, Parkinsonian Disorders.
- diagnosis : Blepharospasm.
- drug therapy : Apraxias.
- etiology : Apraxias.
- pathology : Brain Stem, Cerebellum, Parkinsonian Disorders.
- physiopathology : Apraxias, Brain Stem, Cerebellum, Eyelids.
- Adult, Female, Humans, Infection, Magnetic Resonance Imaging, Male, Middle Aged.
Url:
DOI: 10.1002/mds.21367
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003E56
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :003E56
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001A93
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002860
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002860
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002942
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001A79
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001A79
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001A79
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003F07
Links to Exploration step
ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title>
<author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name>
</author>
<author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name>
</author>
<author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name>
</author>
<author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21367</idno>
<idno type="url">https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E56</idno>
<idno type="wicri:Area/Istex/Curation">003E56</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A93</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Kanazawa M:botulinum:toxin:a</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17266083</idno>
<idno type="wicri:Area/PubMed/Corpus">002860</idno>
<idno type="wicri:Area/PubMed/Curation">002860</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002942</idno>
<idno type="wicri:Area/Ncbi/Merge">001A79</idno>
<idno type="wicri:Area/Ncbi/Curation">001A79</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A79</idno>
<idno type="wicri:doubleKey">0885-3185:2007:Kanazawa M:botulinum:toxin:a</idno>
<idno type="wicri:Area/Main/Merge">003F07</idno>
<idno type="wicri:Area/Main/Curation">002F85</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title>
<author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Brain Research Institute, Niigata University, Niigata</wicri:regionArea>
<wicri:noRegion>Niigata</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-03-15">2007-03-15</date>
<biblScope unit="vol">22</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="597">597</biblScope>
<biblScope unit="page" to="598">598</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno>
<idno type="DOI">10.1002/mds.21367</idno>
<idno type="ArticleID">MDS21367</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Apraxias (drug therapy)</term>
<term>Apraxias (etiology)</term>
<term>Apraxias (physiopathology)</term>
<term>Blepharospasm (diagnosis)</term>
<term>Botulinum Toxins, Type A (therapeutic use)</term>
<term>Brain Stem (pathology)</term>
<term>Brain Stem (physiopathology)</term>
<term>Cerebellum (pathology)</term>
<term>Cerebellum (physiopathology)</term>
<term>Eyelids (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Infection</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurodegenerative Diseases (complications)</term>
<term>Neuromuscular Agents (therapeutic use)</term>
<term>Parkinsonian Disorders (complications)</term>
<term>Parkinsonian Disorders (pathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Neuromuscular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neurodegenerative Diseases</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Blepharospasm</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Apraxias</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Apraxias</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain Stem</term>
<term>Cerebellum</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Apraxias</term>
<term>Brain Stem</term>
<term>Cerebellum</term>
<term>Eyelids</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Infection</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002F85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508 |texte= Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |